Safety and immunogenicity of a highly attenuated rVSVN4CT1-EBOVGP1 Ebola virus vaccine: a randomised, double-blind, placebo-controlled, phase 1 clinical trial.

David K Clarke,Rong Xu,Demetrius Matassov,Theresa E Latham,Ayuko Ota-Setlik,Cheryl S Gerardi,Amara Luckay,Susan E Witko,Luz Hermida, Terry Higgins,Marc Tremblay,Susan Sciotto-Brown, Tracy Chen,Michael A Egan, Janice M Rusnak, Lucy A Ward,John H Eldridge

The Lancet Infectious Diseases（2020）

引用 21|浏览26

暂无评分

摘要

US Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense: Joint Project Manager for Chemical, Biological, Radiological and Nuclear Medical.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要